Month: June 2023

Global International

BenevolentAI announces restructure and strategic focus

BenevolentAI, a clinical-stage AI-enabled drug discovery and development company, has published its strategic plan for a “new era in AI”. The company has outlined its focus to prioritise high-potential products to value inflection points, develop new products to capitalise on the “vast potential of AI”, and progress a proposed headcount reductions […]